The FDA: How America’s Watchdog became a FOOD & PHARMA Industry puppet.

corruption and collusion has created the most unhealthy and most medicated population on earth

The Food and Drug Administration (FDA) stands as one of the most powerful regulatory bodies in the United States, tasked with ensuring the safety of food, drugs, and medical devices. Yet its history reveals a pattern of systemic failure, corruption, and corporate influence that has often compromised its ability to fulfill its mandate. From its origins in the early 20th century to its controversial actions in the present day, the FDA has been both lauded for its vigilance and criticized for prioritizing industry profits over public health. In this article I share the FDA’s trajectory, starting as a well intentioned agency of the people, exploring its successes, abysmal failures, and the reforms necessary to restore its completely absent integrity.

The Origins of the FDA: A Promising Beginning

The FDA traces its roots to the 1906 Pure Food and Drug Act, enacted in response to public outrage over rampant food and drug adulteration. Spearheading this effort was Dr. Harvey Wiley, head of the Bureau of Chemistry, who conducted groundbreaking experiments exposing the dangers of common food additives such as borax, salicylic acid, and formaldehyde. These tests, often conducted on young, Federally employed, healthy volunteers, revealed how these substances caused chronic health issues even at low doses, as experiments done with food additives and pharmaceutical compounds had a very negative impact on the volunteer’s health.

While the public supported Wiley’s mission, (who wouldn’t?) food industry lobbyists with profits now in jeopardy, quickly mobilized to undermine his every effort. Their influence extended to Congress and the Department of Agriculture, which began restricting Wiley’s authority almost immediately. Initially, President Theodore Roosevelt strongly supported Wiley's efforts and resisted industry interference, shielding him from their influence. However, Roosevelt eventually shifted his stance, aligning with industry interests. He established an unauthorized board, bypassing the provisions of the 1906 Food and Drug Act, which systematically undermined and overruled Wiley's initiatives.

Wiley’s eventual resignation in 1912 marked a turning point, as the agency began shifting from its original mission of safeguarding public health to accommodating corporate interests, and they’ve been doing so ever since. This lead to the complete and utter paralysis of food law.

Since Wiley’s time, these industries slowly captured the FDA, CDC, and the NIH, placing former food and pharmaceutical industry CEOs in the highest positions of power within these agencies to cater to the every whim of the food conglomerates and medical mafia to do their bidding. These agencies are utterly powerless and exist merely to create the illusion that someone within the federal system is genuinely committed to safeguarding our well-being. Nothing could be further from the truth.

Over the last four decades, corporate lobbyists have systematically infiltrated regulatory systems, embedding thousands of cheap, toxic substances into the American food supply and medications. These additives, designed solely to slash production costs, remain legal in the U.S. despite being banned across Europe. Hidden behind the deceptive label of “Generally Recognized as Safe” (GRAS), this loophole—crafted by lobbyists and rubber-stamped by a complicit government—enables food conglomerates and pharmaceutical giants to essentially self-regulate the morally suspect, safety of their own ingredients, prioritizing profits over public health.

Contrary to popular belief, the FDA does not evaluate the safety of these substances. Instead, we are expected to trust the corporations bribing politicians to assure us their products are safe. This is not regulation—it’s institutionalized corruption disguised as oversight. Very little regulation exists regarding the widespread use of untested synthetic chemical compounds, regardless of their toxicity. It’s important to note, these agencies receive over half their funding from the very companies they’re suppose to be regulating.

"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair

It’s worth noting that RFK has consistently highlighted a significant national security concern: a recent Pentagon study revealed that 77% of young Americans are unfit for military service due to pre-existing health conditions, such as obesity. Source. This overarching disparity in American health, highlight the grim state of affairs governing the health and safety of what we choose or choose not to consume.

The Kefauver–Harris Amendment and the Rise of Efficacy Standards

The 1960s brought a major crisis that reshaped the FDA’s role. The thalidomide disaster, which caused severe birth defects globally, spurred Congress to grant the agency expanded authority through the Kefauver–Harris Amendment in 1962. This legislation required manufacturers to prove both the safety and efficacy of their products before they could reach the marketplace.

While this new standard was necessary to prevent future tragedies, it inadvertently created tremendous barriers to innovation and many felt it slowed advancement. Randomized controlled trials (RCTs) became the gold standard for proving efficacy, but their high cost made it nearly impossible for smaller companies or natural therapies to gain approval. As a result, the FDA became increasingly reliant on pharmaceutical companies to conduct trials, creating a system vulnerable to manipulation and corruption. This pay-to-play dynamic ensured that only well-funded pharmaceutical companies could navigate the approval process, sidelining promising but unpatentable therapies.

The FDA’s War on Natural Medicine

One of the most contentious and egregious aspects of the FDA’s history has been its treatment of natural and alternative therapies. These treatments, often inexpensive and difficult to patent, pose a direct threat to the pharmaceutical industry’s profitability. This is why pharmaceutical industry in conjunction with the media industry outlets spend innumerable sums of money on endless propaganda, sponsoring every sporting event, the Olympics, Holiday Parade, nationally recognized event, ads at every commercial break on mainstream media from 6 am - 12 - pm, and in every publication imaginable to convince the American public their body is a feeble product of nature that can barely survive on the planet without constant pharmaceutical intervention. And guess what? People buy it!

The food companies knowingly and willingly poison the public for profit. When the masses are made sick with industry sponsored chronic diseases, we ship them over to the pharmaceutical companies hedgemen and drug pushers, not to cure, but to treat, manage, and mask symptoms under the guise that we are helping to improve human health. Simply put, and this cannot be contested; pharmaceutical drugs do not cure a single disease and with good reason. There is no money in a business model that “cures.” It’s not sustainable. But, managing symptoms by blocking natural functions of the body that alleviate/suppress symptoms, never going after the root cause, provides an endless stream of revenue and profits for investors. And that make those with piles of money invested on Wall Street very, very happy.

The FDA’s suppression of natural therapies, which in almost every trial outperform the medical industry’s pharmaceutical synologues (synthetic analogue to something natural - since companies cannot patent nature), has been systematic, targeting even natural cures with extensive evidence of safety and efficacy.

A prime example is dimethyl sulfoxide (DMSO), which I’ve written about here: DMSO: Nature’s Cure For Just About Everything, You Were Never Meant To Discover, a natural compound with remarkable therapeutic potential for almost every imaginable condition including:

• Neurological and circulatory disorders (e.g., strokes, dementia, Raynaud’s, varicose veins).

• Tissue injuries (e.g., sprains, concussions, burns, surgical wounds).

• Chronic pain (e.g., disc issues, arthritis, bursitis).

• Autoimmune and protein disorders (e.g., scleroderma, amyloidosis, interstitial cystitis).

• Head-related issues (e.g., tinnitus, vision loss, sinusitis).

• Internal organ diseases (e.g., pancreatitis, infertility, liver cirrhosis).

• Various cancers, infections, and skin conditions.

It’s important to note that no science has been presented by the FDA in what it sees as the most polarizing drug (which by the way, is NOT A DRUG! It’s a completely natural compound derived from wood), in contesting its use or applications.

Despite widespread support from patients and researchers in the 1960s, the FDA declared DMSO dangerous without any credible evidence. This decision effectively buried the therapy for decades, demonstrating how regulatory barriers disproportionately harm natural medicine and serves to prop up the pharmaceutical industry despite innumerable examples of approved drugs having disastrous outcomes.

Similarly, γ-Hydroxybutyric acid (GHB), a compound with profound benefits for deep restorative sleep and muscle recovery, was demonized and reclassified as a controlled substance under the guise of preventing misuse. The FDA’s actions ignored its therapeutic value and instead prioritized pharmaceutical alternatives, which proved far less effective and more harmful.

The FDA & Medical Mafia Collusion / Monopoly

In recent tweet on X, Robert F. Kennedy Jr. wrote:

As a lawyer who has gone head to head with the FDA & BIG PHARMA on countless occasions and won, RFK Jr. is very well aware of the collusion that exists on a corporate level, lining the pockets of investors and CEO’s both in these companies and those in high places at the FDA, this tweet clearly reflects his determination to finally do something about it.

The American Medical Association’s (AMA’s) original playbook was to pressure pharmaceutical (or cigarette) companies to sponsor the AMA in return for the AMA’s seal of approval on their pharmaceutical.

In time, it evolved into the FDA targeting each viable natural therapy and then pressuring the inventors to sell their rights to the AMA in return for the AMA “proving” the therapy worked, or if they didn’t sell out, the AMA burying it.

The American Medical Association (AMA) began targeting natural medicine and therapies in the early 20th century, particularly after the Flexner Report of 1910. Commissioned by the Carnegie Foundation and supported by the AMA, the report emphasized the need for standardized medical education based on a scientific model, effectively discrediting schools that taught homeopathy, naturopathy, and other natural therapies. This led to the closure of many institutions focusing on alternative medicine.

By the 1930s and 1940s, the AMA ramped up its efforts against natural remedies, labeling them as "quackery." This period saw intensified collaboration between the AMA, government agencies like the FDA, and the pharmaceutical industry to promote synthetic drugs while discrediting natural cures. The creation of the AMA’s Council on Quackery in 1963 further institutionalized the campaign against alternative medicine, targeting practices such as chiropractic care and natural therapies. Source

It wasn’t long before countless natural treatments were sidelined as the government/FDA increasingly aligned with the AMA. This ongoing smear campaign against every natural, isn’t due to a lack of scientific support; natural cures are extensively researched and evidence-based. However, these nearly cost-free remedies threaten the AMA's control over healthcare, leading to censorship and suppression to maintain industry profits at the expense of true healing and recovery.

The FDA’s Role in Vaccine Controversies

The FDA’s handling of vaccine approvals has drawn significant scrutiny over the years. Historical examples, such as the contamination of the polio vaccine with SV-40 (a cancer-causing virus), illustrate the agency’s tendency to protect corporate interests over public safety. The rushed approval of COVID-19 vaccines during the pandemic exposed similar patterns, with regulatory processes completely bypassed or manipulated to accelerate distribution. It has now been proven the mRNA vaccines had virtually no efficacy whatsoever, and yet, presented countless risks (3000+ side effects), that Pfizer and Moderna did everything they could to suppress and keep from the public. No one was prosecuted and 573 new billionaires (yes, billionaires) were created - one every 30 hours during the pandemic. Source

The HPV vaccine provides another case study in regulatory overreach. Despite clinical trials revealing high rates of severe adverse effects, including autoimmune disorders and death, the FDA approved the vaccine and supported aggressive marketing campaigns. Public backlash was met with dismissive responses, deepening mistrust in the agency.

These actions underscore a troubling reality: once the FDA approves a product, it rarely revisits or reverses its decision, even in the face of mounting evidence of harm. This rigidity erodes public confidence and perpetuates the use of unsafe products.

Systemic Challenges and Failures

The FDA’s failures stem from systemic issues that extend far beyond individual controversies. These persistent challenges include:

Regulatory Capture

The FDA has long been criticized for its "revolving door" policy, where individuals frequently transition between regulatory positions within the FDA and lucrative roles within the pharmaceutical industry. In other words, the industry takes care of their own. All the criminals and all those culpable for profiteering at the erosion of human health are all in bed together.

This exchange creates significant conflicts of interest, as regulators may hesitate to enforce stringent policies against companies they aim to work for in the future. You don't want to bite their hand that is feeding you. Conversely, pharmaceutical executives entering the FDA bring biases that favor industry interests over public health. This cycle fosters an environment where decisions are influenced more by corporate profitability than by scientific integrity or public safety which were discarded a long time ago.

One example is the approval of high-profile drugs like Vioxx and certain antidepressants, which later proved extremely harmful with countless deaths involved. Critics argue that financial ties and post-agency employment opportunities for FDA officials played a role in these decisions. This systemic issue erodes public trust and compromises the agency’s ability to act as an impartial guardian of health.

Overreach and Bias

Referenced above, the FDA’s mandate to ensure drug efficacy, introduced by the Kefauver–Harris Amendment, has evolved into an overly rigid framework that stifles innovation. The agency’s insistence on randomized controlled trials (RCTs) as the gold standard for efficacy has made drug approval an expensive, time-consuming process. This has created a barrier to entry for smaller innovators and natural therapies, many of which lack the financial backing to meet these requirements despite demonstrated safety and effectiveness.

Meanwhile, the FDA’s selective enforcement disproportionately targets natural and alternative therapies, often labeling them as unproven or unsafe. At the same time, the agency has approved pharmaceutical products with questionable trial data, later found to be manipulated, bought and paid for by corporate interests, such as opioid medications, leading to public health crises. This disparity highlights a troubling bias in favor of pharmaceutical giants and a tremendous hurdle to overcome for small, innovated companies with highly efficacious natural remedies kept from the public.

Resource Limitations

Chronic underfunding and understaffing further undermine the FDA’s mission. The agency is responsible for regulating a vast array of products, from food additives to complex biologics (pharmaceutical applications), yet it lacks the resources to thoroughly evaluate all submissions. As a result, the FDA increasingly relies on pharmaceutical companies to conduct and interpret their own clinical trials. The inmates are literally running the asylum. This outsourcing compromises the agency’s objectivity, as companies can manipulate data or selectively report results to favor their products.

Moreover, the FDA’s limited resources hinder its ability to conduct post-market surveillance. This means many drugs and devices remain on the market despite emerging evidence of harm, as the agency lacks the capacity to act swiftly and decisively.

Lack of Accountability

Once the FDA approves a product, it rarely revisits or reevaluates its safety, even in the face of new evidence. The agency's reluctance to admit errors stems partly from a fear of undermining its credibility and partly from legal and political pressures. This inertia allows harmful products to remain available, sometimes for decades, before action is taken.

For instance, the delayed removal of dangerous drugs like fen-phen, a weight-loss drug linked to heart and lung damage, demonstrates the agency’s failure to prioritize patient safety over institutional reputation. Similarly, controversies over vaccines and medical devices reveal the FDA’s tendency to defend its initial decisions, even when substantial evidence suggests reevaluation is warranted.

This systemic dysfunction calls for significant reforms to restore the FDA’s credibility and effectiveness, something RFK Jr. is targeting with the new Trump Administration. By addressing these issues, the agency can better fulfill its mandate to protect public health in an increasingly complex and high-stakes regulatory environment.

Proposed Reforms: A Path to Restoration

Addressing these systemic issues requires a comprehensive overhaul of the FDA’s structure and practices. Key reforms include:

1. Transparency and Public Involvement: Requiring all trial data to be publicly accessible would allow independent researchers to identify safety signals and hold manufacturers accountable.

2. Dual Approval Pathways: Creating separate tracks for natural therapies and conventional drugs would ensure that both are evaluated fairly, without imposing prohibitive costs on unpatentable treatments.

3. Conflict of Interest Safeguards: Imposing strict penalties for financial conflicts of interest among regulators and advisory panel members would help rebuild public trust.

4. Revocation Mechanisms: Establishing clear processes for reevaluating and withdrawing harmful drugs from the market is essential to prevent ongoing harm.

5. Empowering States and Courts: Allowing states to challenge FDA decisions and enabling courts to revoke approvals would decentralize authority and provide checks on regulatory overreach.

Conclusion: Restoring Integrity to the FDA

The FDA’s history is a cautionary tale of how an agency created to protect public health can be compromised by systemic corruption and industry influence. Yet its failures also highlight the potential for meaningful reform. By prioritizing transparency, accountability, and structural change, the FDA can reclaim its original mandate and ensure that public health takes precedence over profits. Today, the stakes are higher than ever, but so is the opportunity to rebuild trust and create a regulatory system that serves the needs of all Americans.

An Invitation:

To truly transform your health and overcome chronic fatigue, chronic disease, and other challenges, it's crucial to uncover advanced health strategies and adopt new, healthy lifestyle habits. Imagine making conscious nutritional choices, creating a chemical-free, non-toxic household for your loved ones, and finding companies that provide products with certifiably safe ingredients. Picture yourself with a structured daily fitness regimen (suitable for all levels of fitness), experiencing deep restorative sleep, and effectively managing stress.

I want to personally invite you to explore the SHIFT ETHOS WELLNESS PATHWAYS PROCESS (Tab at the top of this page or link provided below) – a journey back to true health. Dive deeper into these essential elements and experience a comprehensive approach to wellness by enrolling in this revitalizing process, transforming your life, and embracing a healthier you!

Click here: SHIFT ETHOS WELLNESS PATHWAYS PROCESS, to learn more and consider taking the first step towards revitalizing your health. Schedule a free consult by pressing the blue button at the bottom of the WELLNESS PATHWAYS page.

References:

Pentagon Study: A Pentagon study revealed that 77% of young Americans are unfit for military service due to pre-existing health conditions, such as obesity. (Source: [Referenced in the article]).

Flexner Report and AMA: The Flexner Report of 1910, commissioned by the Carnegie Foundation and supported by the AMA, emphasized the need for standardized medical education, discrediting natural therapies. (Source: [Referenced in the article]).

COVID-19 Vaccine Approval and Profits: During the pandemic, 573 new billionaires were created due to mRNA vaccines, raising concerns about efficacy and suppressed risks. (Source: [Referenced in the article]).

Disclaimer:

I am not a medical doctor or a medical practitioner. I am not legally permitted to claim I treat, cure, or heal disease. I can, however, provide educational content with respect to building/restoring and maintaining optimal health through nutrition, diet, sleep support, and exercise, which can reverse health conditions.

Any information provided on this site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this web site.

This website summarizes information on the role of nutrition, diet, and exercise in health, disease and wellness. Readers should be aware that knowledge of nutrition and medicine is constantly evolving. They are encouraged to frequently check the most current information available on preventive and therapeutic measures. It is your designated clinician’s responsibility, relying on their experience and knowledge of the patient, to determine the best course of action in providing care and your choice to follow it or not.

 The author, editor, and publisher of information on this website accepts no liability for any injury arising out of the use of material contained herein, and makes no warranty, express or implied, with respect to the contents of this online publication, or from the contents of sites or articles we provide links to.